Mitochondrial Dysfunction After Repeated Mild Blast Traumatic Brain Injury Is Attenuated by a Mild Mitochondrial Uncoupling Prodrug.
blast injury
dinitrophenol
low-level blast
mitochondria
oxidative stress
Journal
Journal of neurotrauma
ISSN: 1557-9042
Titre abrégé: J Neurotrauma
Pays: United States
ID NLM: 8811626
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
medline:
13
11
2023
pubmed:
21
7
2023
entrez:
21
7
2023
Statut:
ppublish
Résumé
Mild traumatic brain injury (mTBI) results in impairment of brain metabolism, which is propagated by mitochondrial dysfunction in the brain. Mitochondrial dysfunction has been identified as a pathobiological therapeutic target to quell cellular dyshomeostasis. Further, therapeutic approaches targeting mitochondrial impairments, such as mild mitochondrial uncoupling, have been shown to alleviate behavioral alterations after TBI. To examine how mild mitochondrial uncoupling modulates acute mitochondrial outcomes in a military-relevant model of mTBI, we utilized repeated blast overpressure of 11 psi peak overpressure to model repeated mild blast traumatic brain injury (rmbTBI) in rats followed by assessment of mitochondrial respiration and mitochondrial-related oxidative damage at 2 days post-rmbTBI. Treatment groups were administered 8 or 80 mg/kg MP201, a prodrug of 2,4 dinitrophenol (DNP) that displays improved pharmacokinetics compared with its metabolized form. Synaptic and glia-enriched mitochondria were isolated using fractionated a mitochondrial magnetic separation technique. There was a consistent physiological response, decreased heart rate, following mbTBI among experimental groups. Although there was a lack of injury effect in mitochondrial respiration of glia-enriched mitochondria, there were impairments in mitochondrial respiration in synaptic mitochondria isolated from the prefrontal cortex (PFC) and the amygdala/entorhinal/piriform cortex (AEP) region. Impairments in synaptic mitochondrial respiration were rescued by oral 80 mg/kg MP201 treatment after rmbTBI, which may be facilitated by increases in complex II and complex IV activity. Mitochondrial oxidative damage in glia-enriched mitochondria was increased in the PFC and hippocampus after rmbTBI. MP201 treatment alleviated elevated glia-enriched mitochondrial oxidative damage following rmbTBI. However, there was a lack of injury-associated differences in oxidative damage in synaptic mitochondria. Overall, our report demonstrates that rmbTBI results in mitochondrial impairment diffusely throughout the brain and mild mitochondrial uncoupling can restore mitochondrial bioenergetics and oxidative balance.
Identifiants
pubmed: 37476976
doi: 10.1089/neu.2023.0102
pmc: PMC10653072
doi:
Substances chimiques
Prodrugs
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2396-2409Subventions
Organisme : BLRD VA
ID : IK2 BX004618
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM148326
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM148326
Pays : United States
Références
J Spec Oper Med. 2018 Winter;18(4):87-91
pubmed: 30566729
Diabetologia. 2011 Feb;54(2):237-44
pubmed: 20953861
Sci Rep. 2015 Nov 05;5:15075
pubmed: 26537106
Concussion. 2017 Jun 08;2(3):CNC42
pubmed: 30202583
Brain Behav Immun. 2023 May;110:222-236
pubmed: 36907289
Cells. 2019 Mar 23;8(3):
pubmed: 30909602
Exp Neurol. 2009 Aug;218(2):381-9
pubmed: 19477175
Front Endocrinol (Lausanne). 2020 Sep 18;11:556380
pubmed: 33071972
J Neurotrauma. 2010 May;27(5):939-50
pubmed: 20175672
J Neurotrauma. 2023 Mar;40(5-6):561-577
pubmed: 36262047
Brain. 2021 Dec 31;144(12):3788-3807
pubmed: 34972207
J Neurotrauma. 2019 Nov 15;36(22):3063-3091
pubmed: 30794028
J Trauma. 2010 May;68(5):1257-63
pubmed: 20453776
Methods Mol Biol. 2016;1462:119-38
pubmed: 27604716
J Neurotrauma. 2019 Jul 1;36(13):2117-2128
pubmed: 30667346
Neurobiol Aging. 2020 Jan;85:123-130
pubmed: 31718928
Biomedicines. 2023 Jan 24;11(2):
pubmed: 36830865
Antioxidants (Basel). 2023 Feb 07;12(2):
pubmed: 36829963
J Neurosci Res. 2018 Oct;96(10):1677-1688
pubmed: 30063076
Neuroscience. 1997 Oct;80(3):685-96
pubmed: 9276486
Sci Rep. 2018 Jul 13;8(1):10622
pubmed: 30006635
J Neurochem. 1997 Jul;69(1):273-84
pubmed: 9202320
J Neurotrauma. 2017 Apr 1;34(7):1291-1301
pubmed: 27596283
Neurochem Int. 2019 Dec;131:104561
pubmed: 31585135
J Neurotrauma. 2019 Apr 15;36(8):1203-1221
pubmed: 30351225
Trends Neurosci. 2000 Apr;23(4):166-74
pubmed: 10717676
Acta Neuropathol Commun. 2014 Jun 17;2:67
pubmed: 24938728
Exp Neurol. 2019 Jul;317:206-213
pubmed: 30853388
J Neurotrauma. 2013 Jan 1;30(1):30-8
pubmed: 23025820
J Cereb Blood Flow Metab. 2021 Apr;41(4):886-900
pubmed: 32580671
Neuroscience. 2013 Dec 3;253:9-20
pubmed: 23999126
Sci Rep. 2021 Sep 30;11(1):19527
pubmed: 34593828
J Neurotrauma. 2013 Oct 1;30(19):1645-51
pubmed: 23600763
Front Neurol. 2020 Nov 02;11:559318
pubmed: 33224086
Shock. 2015 Aug;44 Suppl 1:71-8
pubmed: 25521536
Neurotox Res. 2010 Aug;18(2):112-23
pubmed: 19949915
Neurobiol Dis. 2022 Apr;165:105634
pubmed: 35077822
J Neurotrauma. 2009 Jun;26(6):815-25
pubmed: 19397423
Ann Neurol. 2003 Jun;53(6):711-7
pubmed: 12783416
Acta Biochim Pol. 2004;51(2):533-8
pubmed: 15218546
J Neurotrauma. 2019 Apr 15;36(8):1252-1263
pubmed: 30417732
Neuroimage. 2011 Jan;54 Suppl 1:S76-82
pubmed: 20385245
Aging Cell. 2008 Aug;7(4):552-60
pubmed: 18505478
Exp Neurol. 2023 May;363:114356
pubmed: 36841465
Front Neurol. 2020 Feb 26;11:91
pubmed: 32174881
J Bioenerg Biomembr. 2004 Aug;36(4):353-6
pubmed: 15377871
Neuroscience. 2018 Aug 21;386:265-283
pubmed: 29960045
J Neurotrauma. 2018 Oct 15;35(20):2435-2447
pubmed: 29808778
J Neurotrauma. 2011 Jan;28(1):95-104
pubmed: 21083431
J Neurotrauma. 2020 Nov 15;37(22):2435-2444
pubmed: 30816062
Neuroscience. 2000;101(2):289-95
pubmed: 11074152
JAMA Netw Open. 2021 Apr 1;4(4):e216445
pubmed: 33861330
Sci Rep. 2019 Jul 4;9(1):9656
pubmed: 31273236
J Neurotrauma. 2005 Oct;22(10):1142-9
pubmed: 16238490
Alzheimers Dement. 2017 May;13(5):582-591
pubmed: 27599210
Mitochondrion. 2023 Jan;68:10-14
pubmed: 36371072
Front Neurol. 2016 Jan 21;7:2
pubmed: 26834697
Biochem Soc Trans. 2003 Dec;31(Pt 6):1300-1
pubmed: 14641047
Front Neurosci. 2019 Jan 23;13:07
pubmed: 30728762
Oxid Med Cell Longev. 2017;2017:7180632
pubmed: 28680531
J Neurotrauma. 2007 May;24(5):798-811
pubmed: 17518535
Int J Mol Sci. 2019 Nov 16;20(22):
pubmed: 31744143
Behav Brain Res. 2018 Jul 16;347:148-157
pubmed: 29526786
Biochim Biophys Acta. 2006 May-Jun;1757(5-6):480-5
pubmed: 16597432
Brain Commun. 2023 Feb 13;5(2):fcad032
pubmed: 36879917
Acta Neuropathol Commun. 2022 Jun 27;10(1):93
pubmed: 35761393
Brain Res. 2003 Mar 21;966(2):312-6
pubmed: 12618355
J Neurochem. 2015 Aug;134(4):677-92
pubmed: 26010875
J Neurochem. 2001 Oct;79(2):266-77
pubmed: 11677254
Q Rev Biophys. 1996 May;29(2):169-202
pubmed: 8870073
Sci Rep. 2021 Mar 15;11(1):5906
pubmed: 33723300
J Neurochem. 1997 Jan;68(1):255-64
pubmed: 8978733
J Neurotrauma. 1998 Oct;15(10):789-98
pubmed: 9814635
J Athl Train. 2001 Sep;36(3):228-235
pubmed: 12937489
Exp Neurol. 2017 Jul;293:83-90
pubmed: 28359739
Biochim Biophys Acta. 1998 Feb 25;1363(2):100-24
pubmed: 9507078
J Neurotrauma. 2019 May 15;36(10):1591-1605
pubmed: 30484371